Diamondback Coronary
Device Vascular
PDI 10852528005169
General payments
$874,195
Research payments
$1,669,490
Through program year 2025, $874,195 in general payments and $1,669,490 in research payments were reported against Diamondback Coronary (Vascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $197,820 | 1,237 |
| 2024 | General | $276,421 | 1,748 |
| 2024 | Research | $923,232 | 171 |
| 2023 | General | $399,955 | 2,231 |
| 2023 | Research | $746,258 | 156 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 50 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 44 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
5,216 general · 327 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.